NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts, according to a Jan. 27 news release.
The two companies initially partnered in 2022 for a development and license agreement for SMAIO’s surgical planning products and commercialization in the U.S. In 2023, NuVasive was acquired by Globus Medical.
With the agreement terminated neither company will receive compensation, and sales restrictions are lifted.
Independent of the split, SMAIO plans to bolster its efforts on U.S. expansion.
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will…
Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its…
Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus…